4 Results for "

RAF mutant-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "RAF mutant-IN-1" in MCE Product Catalog:

Cat. No.: HY-126298
CAS No.: 2340020-82-6
Target:  

Raf

Research Areas:  

Cancer

RAF mutant-IN-1 is a RAF kinase inhibitor, extracted from patent WO2019107987A1, with IC50 values of 21 nM, 30 nM and 392 nM for C-RAF 340D/Y341D, B-RAF V600E and B-RAF WT, respectively .
loading...
    loading...
Cat. No.: HY-158115
CAS No.: 3002056-30-3
Purity:  98.61%
Target:  

Molecular Glues Raf MEK

Research Areas:  

Cancer

NST-628 is a brain-permeable MAPK pathway molecule glue that inhibits RAF phosphorylation and MEK activation. NST-628 also binds RAF and prevents the formation of BRAF-CRAF and BRAF-ARAF heterodimers, effectively inhibiting the RAS-MAPK pathway. NST-628 inhibits RAS- and RAF-driven cancers and demonstrated potent inhibition in mutant KRAS, NRAS, BRAF class II/III, and NF1-mutant tumors .
loading...
    loading...
Cat. No.: HY-142160
CAS No.: 2729996-45-4
Purity:  98.94%
Target:  

Raf

Research Areas:  

Cancer

GNE-9815 (compound 7) is a highly selective, pan-RAF inhibitor with good oral bioavailability. GNE-9815 exhibits Ki values of 0.062 and 0.19 nM for CRAF and BRAF, respectively. GNE-9815 combines with MEK inhibitor Cobimetinib (HY-13064) shows synergistic modulation of MAPK pathway. GNE-9815 can be used in studies of KRAS mutant cancers .
loading...
    loading...
Cat. No.: HY-P10438
Target:  

Raf

Research Areas:  

Cancer

TAT-Braftide is a peptide inhibitor designed to block the dimerization of BRAF, thereby inhibiting its kinase activity. The destruction of BRAF dimer by TAT-Braftide makes BRAF protein more susceptible to proteasome degradation, directly inhibits the activity of BRAF kinase, and reduces the activation of MAPK signaling pathway. Tat-braftide can be used for the role of RAF kinase in MAPK signaling pathway and for the study of BRAF mutant cancers .
loading...
    loading...